KING OF PRUSSIA, PA — XyloCor Therapeutics has dosed the first patient in its Phase 2b EXACT-2 trial evaluating XC001 (encoberminogene rezmadenovec), a novel gene therapy designed to help patients ...

The biotech firm eliminated the need for surgical administration in the study by using an infusion catheter system in a cardiac cath lab.

Analysis from the Thrombotic Thrombocytopenia Syndrome Consortium has provided critical insights into the rare but serious ...

The doctor explained how climate changes can trigger viral infections and affect children and elderly people severely.

For instance, Bharat Biotech's Covaxin uses a traditional technology, while Covishield and Russian Sputnik V are based on an ...

AIIMS experts confirm no link between COVID-19 vaccines and sudden youth deaths, citing studies and reaffirming vaccine ...

A day after the Indian Council of Medical Research debunked claims of the Corona vaccine being responsible for the rising death cases among the youth, a panel of expert doctors from the All India ...

A day after the Indian Council of Medical Research debunked claims of the Corona vaccine being responsible for the rising ...

Researchers from Purdue University and the U.S. Centers for Disease Control and Prevention have recently developed a novel influenza vaccine candidate that uses a bovine adenoviral (BAd) vector to ...